06Mar 2022
Submandibular gland transfer for the prevention of radiation‐induced xerostomia in oropharyngeal cancer: Dosimetric impact in the intensity modulated radiotherapy era

Submandibular gland transfer for the prevention of radiation‐induced xerostomia in oropharyngeal cancer: Dosimetric impact in the intensity modulated radiotherapy era

Submandibular gland (SMG) transfer decreased radiation‐associated xerostomia in the 2/3‐dimensional radiotherapy era. We evaluated the dosimetric implications of SMG transfer on modern intensity-modulated radiotherapy (IMRT) plans.No statistically significant difference in mean SMG dose, or total salivary gland dose was observed with or without SMG transfer. Mean oral cavity and larynx doses were not statistically different. Neither tumour site, target volume crossing midline, stage, nor salivary gland volumes were associated with mean doses. Therefore, IMRT likely decreases the benefit of SMG transfer on the risk of radiation‐associated xerostomia.

  • #ent

Like

Save

Share